What is the CervoMed Inc. stock price forecast?

CervoMed Inc. is currently trading at $2.45. View real-time AI analysis on Alpha Lenz.

What is CervoMed Inc. insider trading activity?

View the latest insider trading data for CervoMed Inc. on Alpha Lenz.

What is CervoMed Inc.'s P/E ratio?

CervoMed Inc.'s P/E ratio is -0.8.

CervoMed Inc.

NASDAQ · CRVO

$2.45+0.01(+0.41%)Pre-market

Ask about CervoMed Inc.'s future dividend policy...

Alpha Chat Insight

“CervoMed Inc. trades at a P/E of -0.8 (undervalued) with modest ROE of -93.9%.”

Ask for details →

Company Overview

CervoMed Inc. is a biotechnology company focused on developing treatments for neurodegenerative diseases. With a commitment to improving patient outcomes, the company engages in the research and development of innovative therapies that target underlying neurological conditions such as Alzheimer's disease and Parkinson's disease. CervoMed Inc. is recognized for its scientific expertise in neurotherapeutics, exploring promising pathways that could lead to breakthrough solutions. Operating within the highly specialized biotech sector, the company contributes to expanding our understanding of neurobiology and developing targeted interventions. By collaborating with academic institutions, healthcare providers, and industry partners, CervoMed Inc. plays a critical role in advancing medical research and offering hope for patients suffering from debilitating neurological disorders.

CEODr. John J. Alam M.D.

Websitehttps://www.cervomed.com

SectorHealthcare

IndustryBiotechnology

Employees15

Company Statistics

FY 2025

Profile

$22.15MMarket Cap

$0.00Revenue

0.00Shares Out

15Employees

Margins

N/AGross

N/AEBITDA

N/AOperating

N/APre-Tax

N/ANet

Valuation

-0.82P/E

1.22P/B

N/AEV/Sales

-0.49EV/EBITDA

-0.94P/FCF

Growth (CAGR)

N/ARev 3Yr

N/ARev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-81.77%ROA

-93.92%ROE

-85.79%ROIC

Financial Health

$8.24MCash & Cash Equivalents

$-3.58MNet Debt

25.55%Debt/Equity

N/AInterest Cov